Vir Biotechnology grants director Suzanne Louise Topalian 12,731 RSUs and 25,462 stock options
VIR•Vir Biotechnology granted director Suzanne Louise Topalian 12,731 common shares and options to buy 25,462 shares at $11.57 each. The options expire on October 26, 2036.
1. Director compensation grant
Vir Biotechnology granted Suzanne Louise Topalian 12,731 common shares on October 27, 2026. She also received options to buy 25,462 shares at an exercise price of $11.57, expiring October 26, 2036.
